Structural and Valvular

TAVR: News & Clinical Trials

Jul 10th, 2023

Clinical Interest Article

The Evolving use of Intracardiac Echocardiography in Structural Heart Disease Interventions

Read More

Jul 10th, 2023

Clinical Interest Article

Scope I Trial: 3 Year Outcomes

Read More

Jul 10th, 2023

Clinical Interest Article

PROTECTED TAVR Misses the Mark

Read More

Mar 6th, 2023

Clinical Interest Article

Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High Risk—Coverage of CRT 2023

Read More

Jan 4th, 2023

Clinical Interest Article

Disparities in Utilization of Advanced Structural Heart Cardiovascular Therapies

Read More

Sep 22nd, 2022

Clinical Interest Article

Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement: The PROTECTED TAVR Study—Coverage of TCT 2022

Read More

Apr 22nd, 2022

Clinical Interest Article

ADAPT-TAVR Trial—Coverage of ACC.22

Routine Use of Edoxaban Post-TAVR in Patients Without an Indication for Anticoagulation Does Not Significantly Reduce Valve Thrombosis or Stroke

Read More

Apr 22nd, 2022

Clinical Interest Article

SURTAVI at 5 Years—Coverage of ACC.22

Self-Expanding TAVR in Intermediate-Risk Patients Non-Inferior to SAVR at 5 Years

Read More

Mar 3rd, 2022

Clinical Interest Article

Low-Risk TAVR Trial 4-Year Results—Coverage of CRT 2022

Read More

Mar 3rd, 2022

Clinical Interest Article

Comparisons of Transcaval and Transaxillary TAVR Alternative Access Routes—Coverage of CRT 2022

Read More

© Society for Cardiovascular Angiography & Interventions

SCAI^® is a registered trademark of the Society for Cardiovascular Angiography & Interventions.

All content found on the Society for Cardiovascular Angiography & Interventions website (www.scai.org) including text, images, audio, video, or other formats is created for informational purposes only. Links to other content are to be taken at your own risk. SCAI is not responsible for the content or claims of external websites.

Get in touch

1100 17th Street NW, Suite 400, Washington, DC 20036

202-741-9854 TEL

800-992-7224 TOLL-FREE

202-689-7224 FAX

Connect

Follow us on social media.